Safety and Efficacy of Multisensory Stimulation Virtual Reality for Stroke Patients.
Launched by FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY · Feb 17, 2024
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new treatment using virtual reality to help stroke patients improve their movement and thinking skills. The study will use multisensory stimulation, which means it will involve sights, sounds, and possibly other sensations to create a more engaging experience for patients. The goal is to see if this innovative approach can make a positive difference in the recovery process for those who have had a stroke.
To participate, individuals need to be between 18 and 85 years old, have experienced their first stroke confirmed by imaging tests like a CT or MRI scan, and be able to walk with some help. They should also be able to follow instructions for the tests and tolerate the rehabilitation training. However, those with serious mental health issues or other medical problems that could affect their participation, or those involved in other clinical trials, won't be eligible. While the study has not yet started recruiting participants, it offers a promising opportunity for stroke survivors looking to enhance their recovery journey through innovative technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Diagnosis of stroke by neuroimaging (CT or MRI) assessment
- • 2. 18-85 years old
- • 3. Be able to walk with minor assistance
- • 4. Can tolerate the rehabilitation training of this experiment
- • 5. First stroke
- • 6. Be able to follow instructions to complete the test
- • 7. Patients who signed informed consent
- Exclusion Criteria:
- • 1. The test could not be tolerated due to organic disease
- • 2. There is a serious mental illness resulting in inability to cooperate with or tolerate this test
- • 3. is participating in another clinical trial involving an investigational drug or physical therapy
- • 4. Patients who have not signed informed consent
About First Affiliated Hospital Of Chongqing Medical University
The First Affiliated Hospital of Chongqing Medical University is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and education. As a prominent sponsor of clinical trials, the hospital is committed to conducting high-quality, ethically-driven studies that contribute to the understanding and treatment of various medical conditions. With a robust infrastructure and a team of experienced researchers and healthcare professionals, the institution fosters collaboration across disciplines to enhance patient care and improve health outcomes. Its strategic focus on translational medicine underscores the hospital's role in bridging the gap between laboratory discoveries and clinical applications, ultimately benefiting patients and the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Dingqun Bai
Study Chair
First Affiliated Hospital of Chongqing Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported